Letters
Colorectal cancer screening
Randomised trials of flexible sigmoidoscopy
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4618 (Published 24 August 2010) Cite this as: BMJ 2010;341:c4618- Wendy Atkin, professor of gastrointestinal epidemiology1,
- Ines Kralj-Hans1,
- Jane Wardle2,
- Stephen Duffy3
- 1Department of Surgery and Cancer, Imperial College London, Wright-Fleming Building (Level 5), St Mary’s Campus, London W2 1PG
- 2Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, London
- 3Cancer Research UK Centre for EMS, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London
- w.atkin{at}imperial.ac.uk
Bretthauer’s editorial contains two incorrect statements about the outcomes of the UK flexible sigmoidoscopy trial (UKFSST).1 2
Firstly, the subtitle, “Flexible sigmoidoscopy shows promise, but randomised trial data are needed,” is misleading because UKFSST is a randomised controlled trial. It involved 170 000 people and reduced the mortality of colorectal cancer by 43% and incidence by 33% in screening attenders.
Secondly, the absolute …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.